Polyclonal hypergammaglobulinaemia: towards definition of a threshold.

adult pathology biochemistry immunology

Journal

Postgraduate medical journal
ISSN: 1469-0756
Titre abrégé: Postgrad Med J
Pays: England
ID NLM: 0234135

Informations de publication

Date de publication:
07 Feb 2022
Historique:
received: 03 06 2021
accepted: 18 01 2022
medline: 7 2 2022
pubmed: 7 2 2022
entrez: 19 04 2023
Statut: aheadofprint

Résumé

Polyclonal hypergammaglobulinaemia (PH) represents a classic diagnosis problem in internal medicine. However, there is no consensus threshold for PH. The aim of this study was to define a threshold for PH. We conducted a retrospective multicentric study using laboratory biological databases between 1 January 2016 and 31 December 2016 in two university hospitals and one non-university hospital. All patients 18 years old or over and with at least one serum protein electrophoresis (SPE) available in 2016 were included. Exclusion criteria were monoclonal, biclonal, or oligoclonal spikes or, in case of hypogammaglobulinaemia, proven free light chain gammopathy. The main endpoint was to define the threshold values for PH in this population. Another objective was to define the 95th percentile of the distribution. 20 766 SPEs were included in this cohort. The PH threshold on 95th percentile was 18.9 g/L. The threshold varied according to geographical areas. This is the first study to scientifically define a PH threshold. The main limitation is that our threshold is only biological. The study was not designed to associate this threshold with a clinically active disease. In conclusion, while the 19 g/L cut-off seems the most relevant threshold, but it will need to be validated by prospective studies.

Sections du résumé

BACKGROUND BACKGROUND
Polyclonal hypergammaglobulinaemia (PH) represents a classic diagnosis problem in internal medicine. However, there is no consensus threshold for PH. The aim of this study was to define a threshold for PH.
METHODS METHODS
We conducted a retrospective multicentric study using laboratory biological databases between 1 January 2016 and 31 December 2016 in two university hospitals and one non-university hospital. All patients 18 years old or over and with at least one serum protein electrophoresis (SPE) available in 2016 were included. Exclusion criteria were monoclonal, biclonal, or oligoclonal spikes or, in case of hypogammaglobulinaemia, proven free light chain gammopathy. The main endpoint was to define the threshold values for PH in this population. Another objective was to define the 95th percentile of the distribution.
RESULTS RESULTS
20 766 SPEs were included in this cohort. The PH threshold on 95th percentile was 18.9 g/L. The threshold varied according to geographical areas.
CONCLUSIONS CONCLUSIONS
This is the first study to scientifically define a PH threshold. The main limitation is that our threshold is only biological. The study was not designed to associate this threshold with a clinically active disease. In conclusion, while the 19 g/L cut-off seems the most relevant threshold, but it will need to be validated by prospective studies.

Identifiants

pubmed: 37073601
pii: 7127883
doi: 10.1136/postmj/postgradmedj-2021-140591
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of Postgraduate Medical Journal. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Chloé Baillou (C)

Service de médecine interne, maladies infectieuses et tropicales, CHU Poitiers, Poitiers, France.
Université de Poitiers, Poitiers, France.

Florence Jacomet (F)

Service d'immunologie et inflammation, CHU Poitiers, Poitiers, France.

Thomas Dejoie (T)

Laboratoire de biochimie, CHU Nantes, Nantes, France.

Pierre Lureau (P)

Laboratoire de biologie médicale, CH Niort, Niort, France.

Clément Beuvon (C)

Service de médecine interne, maladies infectieuses et tropicales, CHU Poitiers, Poitiers, France.
Université de Poitiers, Poitiers, France.

Aurélie Grados (A)

Service de médecine interne, CH Niort, Niort, France.

Pauline Martins (P)

Service de médecine interne-rhumatologie, CH La Rochelle, La Rochelle, France.

Pascal Roblot (P)

Service de médecine interne, maladies infectieuses et tropicales, CHU Poitiers, Poitiers, France.
Université de Poitiers, Poitiers, France.

Mathieu Puyade (M)

Service de médecine interne, maladies infectieuses et tropicales, CHU Poitiers, Poitiers, France.

Mickael Martin (M)

Service de médecine interne, maladies infectieuses et tropicales, CHU Poitiers, Poitiers, France.
Université de Poitiers, Poitiers, France.

Classifications MeSH